The greatest challenge to improving human stem cell derived ? (SC-?) cell technologies and in turn impeding advancements in diabetes cell therapeutics and disease modeling is our lack of knowledge on human ? cell functional maturation. In my recently published first author publication I develop a protocol for the generation of SC-? cells with insulin secretion dynamics approaching that of primary human islets and reveal that permitting TGF? signaling is important for SC-? cell functional maturation. In additional preliminary data, I have identified that SIX2 is upregulated in TGF? permitted cells and that SIX2 is necessary for SC-? cell function. In this project I will investigate TGF? signaling and SIX2 expression in the context of SC-? differentiation and functional maturation. I hypothesize that TGF? signaling via SIX2 transcriptional activity is critical for SC-? cell development and functional maturation. An understanding of TGF? signaling in ? cell functional maturation is not clear, with limited literature on the topic and the data being confounding and often contradictory with some reports claiming TGF? signaling benefits and other harm ? cell function. This proposal will help clarify the ambiguity associated with TGF? and functional maturation. SIX2 is a recently identified ? cell specific transcription factor within the islet of Langerhans and is linked to diabetes by GWAS studies. The regulatory role of SIX2 in pancreatic and ? cell development and functional maturation has not been characterized. SIX2 is not expressed in mouse ? cells making our SC-? cell differentiation model critical for investigating its role in pancreatic and ? cell differentiation and functional maturation. To investigate the role of TGF? signaling in SC- ? cell functional maturation I will determine which SMADS and TGF? ligands drive the functional maturation observed as well as the downstream mechanism driving the functional maturation using a combination of knockdown, overexpression, and RNA sequencing techniques. To investigate SIX2 action in SC-? cell differentiation and functional maturation I will determine SIX2 expressing populations through the differentiation using immunostaining and a SIX2 knockout human pluripotent stem cell line. I will investigate SIX2 role on SC- ? cell functional maturation using RNA sequencing techniques and robust functional characterization employing calcium imaging, transmission electron microscopy, and insulin/proinsulin protein content assays. This work will elucidate the role of TGF? and SIX2 on SC-? cell functional maturation.
Aim 1. Investigate TGF? signaling in SC-? cell functional maturation.
Aim 2. Characterize SIX2 in SC-? cell differentiation and functional maturation.

Public Health Relevance

Human pluripotent stem cell derived ? (SC-?) cells have immense potential for diabetes cell replacement therapy. Current SC-? cells have lower function than primary ? cells. This project aims to understand how TGF? signaling and SIX2 expression regulate SC-? cell functional maturation with aims to improve SC-? cell function. Improved SC-? cells will facilitate diabetes cell therapy, disease modeling, and drug screening.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Predoctoral Individual National Research Service Award (F31)
Project #
1F31DK125068-01A1
Application #
10141873
Study Section
Special Emphasis Panel (ZDK1)
Program Officer
Rivers, Robert C
Project Start
2020-09-01
Project End
2022-08-31
Budget Start
2020-09-01
Budget End
2021-08-31
Support Year
1
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130